Royal Bank of Canada
TVGN icon

Royal Bank of Canada’s Tevogen Inc. Common Stock TVGN Stock Holding History

Royal Bank of Canada’s Portfolio TVGN Stock Details TVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1K Buy
121
+82
+210% +$1K ﹤0.01% 6982
2025
Q4 		$0 Sell
39
-7
-15% -$182 ﹤0.01% 7728
2025
Q3 		$2K Sell
46
-61
-57% -$3K ﹤0.01% 6925
2025
Q2 		$6K Buy
107
+93
+664% +$5.3K ﹤0.01% 6616
2025
Q1 		$1K Sell
14
-28
-67% -$1.84K ﹤0.01% 6733
2024
Q4 		$3K Sell
42
-75
-64% -$4.89K ﹤0.01% 6675
2024
Q3 		$2K Buy
117
+76
+185% +$2.22K ﹤0.01% 6668
2024
Q2 		$1K Buy
+41
New +$2.67K ﹤0.01% 6931

Other funds holding TVGN

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Royal Bank of Canada's TVGN Position: Q1 2026 in Review

Royal Bank of Canada increased its Tevogen Inc. Common Stock (TVGN) stake by 210% in Q1 2026, buying an estimated $1K and bringing the position to 121 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #6982.

Royal Bank of Canada first reported a position in TVGN in Q2 2024 and has held it in 8 quarters since. The position peaked at $6K in Q2 2025. 30 funds tracked by Wall St. Rank hold TVGN as of Q1 2026.

  • Royal Bank of Canada held 121 shares of Tevogen Inc. Common Stock worth $1K as of Q1 2026.
  • Royal Bank of Canada bought 82 Tevogen Inc. Common Stock shares in Q1 2026, an estimated $1K.
  • Tevogen Inc. Common Stock made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6982 holding.
  • Royal Bank of Canada first reported a position in Tevogen Inc. Common Stock in Q2 2024 and has held it in 8 quarters since.
  • Royal Bank of Canada's Tevogen Inc. Common Stock position peaked at $6K in Q2 2025.
  • 30 funds tracked by Wall St. Rank held Tevogen Inc. Common Stock as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.